Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
about
Alzheimer's Disease: Mechanism and Approach to Cell TherapyRNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic ratsEarly role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.mNos2 deletion and human NOS2 replacement in Alzheimer disease modelsNeocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoGlutathione S-transferases variants as risk factors in Alzheimer's disease.Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.Carqueja (Baccharis trimera) Protects against Oxidative Stress and β-Amyloid-Induced Toxicity in Caenorhabditis elegans.Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's DiseaseRestoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease.Selenium in the Therapy of Neurological Diseases. Where is it Going?An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyOral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study.A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds.Adaptation and sensitization to proteotoxic stress.Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects.ST09, a Novel Thioester Derivative of Tacrine, Alleviates Cognitive Deficits and Enhances Glucose Metabolism in Vascular Dementia Rats.Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.Synthesis of new lipoic acid conjugates and evaluation of their free radical scavenging and neuroprotective activities.Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand.A lysosome-targeted fluorescent sensor for the detection of glutathione in cells with an extremely fast response.Ameliorative effect of betulin from Betula platyphylla bark on scopolamine-induced amnesic mice.Oxidation and ubiquitination in neurodegeneration.Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.Astrocyte plasticity revealed by adaptations to severe proteotoxic stress.Aerobic exercise combined with antioxidative treatment does not counteract moderate- or mid-stage Alzheimer-like pathophysiology of APP/PS1 mice.Optimized-SopungSunkiwon, a Herbal Formula, Attenuates Aβ Oligomer-Induced Neurotoxicity in Alzheimer's Disease Models.Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation.Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and biochemical evidence.Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer's Disease Features Progression in TgCRND8 Mice.N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione.The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition.Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.
P2860
Q26778149-14348879-AEE0-4F09-9A12-52A6961A181EQ30418181-FFFC1BD9-FDB6-4FDF-A99D-539D7E94E101Q31109560-5E35BA28-6D6A-4EAA-B011-4D35D34E8BB2Q33783000-BE14F55B-9656-4149-A45C-D83A9614AB64Q34041402-3F82A869-8EC4-47A2-A571-6908D72A7814Q34639246-828E6573-4F5D-4853-8348-17E31AD6C5C3Q35633545-AC59697A-16FE-4C24-B905-45FD734E7F4BQ35801845-963F731E-C7E9-47A6-BE79-0993A671EE69Q35868787-1FEE4C52-7344-43B9-95CD-B384590ADF99Q36441971-4458B23B-2B9B-493D-B8FA-807756F02654Q36638616-2707574A-0120-44C3-9286-3C575697DC1DQ36872331-ED79C378-B9C6-43AF-951D-3F55E2C0C6F0Q37219282-4BCBEDE2-0C9B-4BA9-868F-D39C99C6733AQ37617099-CA832FAF-B75A-4326-8A3D-E96CE0BEE7A6Q37625524-60F93607-0994-456C-9F29-6D681920963DQ37651678-F0B5CD38-4127-4CBB-AD1C-E458196B1005Q38019418-70638FCB-A2BB-4340-A12D-EC26C7547367Q38086474-B204DE71-27D3-4C0F-8099-CCEB904321E7Q38315769-B5A002BA-8333-43DE-AB85-CBB7D9599BBFQ38367422-C19024A6-700D-4951-9903-BDF5E7CD8D41Q38799274-2385C53A-0ABF-4979-A57B-38D23441FB7EQ39019452-91B10860-D916-46A5-9957-C5A279B3AD3AQ39034930-ACDE38E3-918E-406A-B04D-E71CC4C5C4ABQ40484991-15743E42-3122-450B-BC5C-87F991E5DEA9Q40590697-B1738A72-558F-4AA8-844F-80C719C22F7BQ42481246-0DE834A3-7786-4712-81C4-C8433A39709EQ44555978-43204476-9E2F-47DD-AB64-5205DA15798CQ44793917-047B47CB-1E77-46DA-BC7F-C3426EC2A207Q45167511-1CD54D15-0691-42B7-9861-6A3A64EAF39FQ45323391-CC64EFC3-69FE-49D5-AF27-CEB766D5FC88Q46241778-1B3BE5A6-55CD-43D4-9FD9-51A72C9267DFQ46638758-990DB130-1A7A-413C-A562-8C8824D24F48Q46784328-166D5E82-1D82-49D0-9CC5-2D3EF0208801Q46853871-CF2355FE-07E6-4878-AD65-9F5020B6249BQ46914176-D3BFDCB0-4520-477E-A6A4-634214A27A68Q46979323-598090FA-1208-48B1-8399-33BF219251EEQ47099731-9F3A5A43-A601-4BA1-B535-8BD3D88E6265Q47919698-0B194063-D4A6-4719-9405-B6BA29EFB2C2Q48091363-96CECA8A-FCAA-4D40-AC20-B1B94D75DFB4Q48314660-D233A293-6A70-4437-B133-EFCFBCE21D52
P2860
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@en
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@nl
type
label
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@en
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@nl
prefLabel
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@en
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@nl
P2860
P1476
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
@en
P2093
Chava B Pocernich
P2860
P304
P356
10.1016/J.BBADIS.2011.10.003
P407
P577
2011-10-12T00:00:00Z